Nature’s Sunshine Products, Inc. (NASDAQ:NATR) Shares Sold by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. lowered its position in Nature’s Sunshine Products, Inc. (NASDAQ:NATR) by 7.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 68,933 shares of the company’s stock after selling 5,759 shares during the quarter. Charles Schwab Investment Management Inc. owned 0.37% of Nature’s Sunshine Products worth $939,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Bank of New York Mellon Corp boosted its stake in shares of Nature’s Sunshine Products by 12.6% in the second quarter. Bank of New York Mellon Corp now owns 48,589 shares of the company’s stock valued at $732,000 after purchasing an additional 5,425 shares during the period. Bailard Inc. acquired a new stake in shares of Nature’s Sunshine Products during the second quarter worth approximately $197,000. Skylands Capital LLC increased its stake in shares of Nature’s Sunshine Products by 722.1% in the second quarter. Skylands Capital LLC now owns 333,101 shares of the company’s stock worth $5,020,000 after buying an additional 292,581 shares during the last quarter. Panagora Asset Management Inc. boosted its stake in Nature’s Sunshine Products by 8.3% during the 2nd quarter. Panagora Asset Management Inc. now owns 70,338 shares of the company’s stock valued at $1,060,000 after acquiring an additional 5,392 shares during the last quarter. Finally, American Century Companies Inc. boosted its stake in Nature’s Sunshine Products by 25.7% during the 2nd quarter. American Century Companies Inc. now owns 260,479 shares of the company’s stock valued at $3,925,000 after acquiring an additional 53,221 shares during the last quarter. 79.40% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on NATR shares. StockNews.com raised shares of Nature’s Sunshine Products from a “buy” rating to a “strong-buy” rating in a report on Tuesday, September 10th. Canaccord Genuity Group assumed coverage on Nature’s Sunshine Products in a research note on Friday, September 13th. They issued a “buy” rating and a $18.00 target price for the company. Finally, Canaccord Genuity Group assumed coverage on Nature’s Sunshine Products in a report on Friday, September 13th. They set a “buy” rating and a $18.00 target price for the company.

Insider Transactions at Nature’s Sunshine Products

In other Nature’s Sunshine Products news, major shareholder Fosun Pharmaceutical Shanghai sold 3,000 shares of the firm’s stock in a transaction dated Thursday, October 10th. The shares were sold at an average price of $13.39, for a total transaction of $40,170.00. Following the transaction, the insider now owns 69,347 shares of the company’s stock, valued at approximately $928,556.33. This trade represents a 4.15 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Over the last three months, insiders sold 7,499 shares of company stock worth $99,802. Company insiders own 4.70% of the company’s stock.

Nature’s Sunshine Products Stock Down 0.3 %

Shares of NASDAQ:NATR opened at $15.65 on Wednesday. Nature’s Sunshine Products, Inc. has a fifty-two week low of $10.81 and a fifty-two week high of $21.72. The company has a market cap of $289.15 million, a PE ratio of 17.78 and a beta of 0.93. The company’s 50-day moving average price is $14.73 and its 200 day moving average price is $14.55.

Nature’s Sunshine Products Company Profile

Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.